Veracyte
Founded in 2006, Veracyte is emerging in the field of molecular cytology by developing molecular tests designed to improve the diagnostic accuracy of cytology samples and also helping to increase the utility of minimally invasive procedures as an alternative to surgical biopsy. The company is headquartered in San Francisco, California.
Last updated on
About Veracyte
Founded
2008Estimated Revenue
$250M-$500MEmployees
251-1KFunding / Mkt. Cap
$681MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
South San FranciscoState
CaliforniaCountry
United StatesVeracyte
Find your buyer within Veracyte